These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 17889463

  • 21. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.
    D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, Corrado F, Triolo O, Rizzo P, Russo S, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Adamo EB, Squadrito F.
    Menopause; 2009; 16(2):301-6. PubMed ID: 19034051
    [Abstract] [Full Text] [Related]

  • 22. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms.
    Al-Azzawi F, Buckler HM, United Kingdom Vaginal Ring Investigator Group.
    Climacteric; 2003 Jun; 6(2):118-27. PubMed ID: 12841882
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L, Gass M, Constantine G, Olivier S, Study 315 Investigators.
    Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
    [Abstract] [Full Text] [Related]

  • 24. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Menopause; 2009 Jan; 16(5):877-82. PubMed ID: 19458560
    [Abstract] [Full Text] [Related]

  • 25. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN.
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [Abstract] [Full Text] [Related]

  • 26. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG, Drosman S, Helmond FA, Stathopoulos VM.
    Menopause; 2006 Sep; 13(6):917-25. PubMed ID: 17006377
    [Abstract] [Full Text] [Related]

  • 27. An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal women.
    Gerlinger C, Gude K, Hiemeyer F, Schmelter T, Schäfers M.
    Menopause; 2012 Jul; 19(7):799-803. PubMed ID: 22228322
    [Abstract] [Full Text] [Related]

  • 28. A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol.
    Gass MS, Rebar RW, Cuffie-Jackson C, Cedars MI, Lobo RA, Shoupe D, Judd HL, Buyalos RP, Clisham PR.
    Maturitas; 2004 Oct 15; 49(2):140-7. PubMed ID: 15474758
    [Abstract] [Full Text] [Related]

  • 29. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H, Al-Azzawi F, UK VR Multicentre Trial Group.
    BJOG; 2003 Aug 15; 110(8):753-9. PubMed ID: 12892687
    [Abstract] [Full Text] [Related]

  • 30. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
    Phillips TJ, Symons J, Menon S, HT Study Group.
    J Am Acad Dermatol; 2008 Sep 15; 59(3):397-404.e3. PubMed ID: 18625536
    [Abstract] [Full Text] [Related]

  • 31. Perimenopausal women in estrogen vasomotor trials: contribution to placebo effect and efficacy outcome.
    Simon JA, Stevens RE, Ayres SA, Phelps KV.
    Climacteric; 2001 Mar 15; 4(1):19-27. PubMed ID: 11379374
    [Abstract] [Full Text] [Related]

  • 32. Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate.
    Palacios S, Farias ML, Luebbert H, Gomez G, Yabur JA, Quail DC, Turbi C, Kayath MJ, Almeida MJ, Mönnig E, Nickelsen T.
    Am J Obstet Gynecol; 2004 Jul 15; 191(1):121-31. PubMed ID: 15295352
    [Abstract] [Full Text] [Related]

  • 33. Long-term follow-up of acupuncture and hormone therapy on hot flushes in women with breast cancer: a prospective, randomized, controlled multicenter trial.
    Frisk J, Carlhäll S, Källström AC, Lindh-Astrand L, Malmström A, Hammar M.
    Climacteric; 2008 Apr 15; 11(2):166-74. PubMed ID: 18365859
    [Abstract] [Full Text] [Related]

  • 34. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women.
    Archer DF, Pickar JH, MacAllister DC, Warren MP.
    Menopause; 2012 Jun 15; 19(6):622-9. PubMed ID: 22282101
    [Abstract] [Full Text] [Related]

  • 35. Low-dose estradiol for climacteric symptoms in Japanese women: a randomized, controlled trial.
    Honjo H, Taketani Y.
    Climacteric; 2009 Aug 15; 12(4):319-28. PubMed ID: 19330598
    [Abstract] [Full Text] [Related]

  • 36. Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women.
    Nedstrand E, Wijma K, Wyon Y, Hammar M.
    Maturitas; 2005 Jun 16; 51(2):154-62. PubMed ID: 15917156
    [Abstract] [Full Text] [Related]

  • 37. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
    Bouchard P, Panay N, de Villiers TJ, Vincendon P, Bao W, Cheng RJ, Constantine G.
    Climacteric; 2012 Feb 16; 15(1):12-20. PubMed ID: 22066790
    [Abstract] [Full Text] [Related]

  • 38. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G, Dvorak V, Genazzani AR, Hamann B, Heikkinen J, Mueck AO, Suzin J, Kawakami FT, Ferreira A, Sun D, Arguinzoniz M.
    Maturitas; 2007 Jun 20; 57(2):171-81. PubMed ID: 17317046
    [Abstract] [Full Text] [Related]

  • 39. A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women.
    Stevens RE, Hanford K, Wason S, Cusack SL, Phelps KV.
    Int J Fertil Womens Med; 2000 Jun 20; 45(4):264-72. PubMed ID: 10997482
    [Abstract] [Full Text] [Related]

  • 40. Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement.
    Campagnoli C, Abbà C, Ambroggio S, Peris C, Perona M, Sanseverino P.
    Maturitas; 2005 Jun 16; 51(2):127-34. PubMed ID: 15917152
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.